01-01-1970 12:00 AM | Source: ICICI Direct
Buy Kotak Mahindra Bank Ltd : Stable performance continues, growth awaited - ICICI Direct
News By Tags | #413 #872 #3961 #80 #1302

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

Buy Kotak Mahindra Bank Ltd For Target Rs.2040

Stable performance continues, growth awaited…

About the stock: Kotak Mahindra Bank (KMB) is a powerful banking franchise, with promoter stake at 26% and strong promoter led management. It has a presence across financial services value chain.

* CASA forms 60.2% of total deposits aiding lower costs

* Strong RoA of 1.8%and RoE of 12-13% make it a good profitable bank

 

Q1FY22 Results: Managed well in Covid environment.

* Advances declined 2.5% QoQ to 2.17 lakh crore, deposits up 9.6% YoY

* NII grew 5.6% YoY, NIMs rose 21 bps QoQ to 4.6%. PAT at | 1640 crore

* GNPA at 3.56% vs. 3.25% QoQ, with nominal rise in restructured book. Slippage for Q1FY22 was | 1500 crore

 

What should investors do?

KMB’s share price has grown by ~2.3x over the past five years (from ~| 745 in March 2016 to ~| 1,740 now).

* We retain our BUY rating on the stock, expecting growth pick-up from Q3FY22 while strong promoter holding provides comfort

Target Price and Valuation: We value standalone bank at ~3.9x FY23E ABV and subsidiaries at | 455 post holding company discount giving SOTP target of | 2040

 

Key triggers for future price performance:

* KMB’s long term focus continues on maintaining risk adjusted returns

* High provision buffer provides comfort regarding volatility in asset quality and, thus earnings

* Consistent performance over a period of time, healthy return ratios ~1.8% RoA & 12-13% RoE with strong management justify valuations

* Subsidiaries like AMC and securities continue strong performance, life insurance and Kotak Prime was impacted

 

Alternate Stock Idea: Apart from Kotak, in our coverage we also like Axis Bank.

* Strong liabilities franchise, adequate capitalisation and healthy provision buffer to aid business growth as well as earnings trajectory.

* BUY with target price of | 900

 

To Read Complete Report & Disclaimer Click Here

 

https://secure.icicidirect.com/Content/StaticData/Disclaimer.html

 

Above views are of the author and not of the website kindly read disclaimer